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Abstract
Background: The treatment of Enterobacteriaceae family including diarrheagenic E. coli (DEC) has been increasingly
complicated due to the emergence of resistant strains. Here we report on the phenotypic resistance profiles and
ESBL genotype and virulence profiles of Enteroaggregative E. coli (EAEC) and Enteropathogenic E. coli (EPEC)
isolated from children hospitalized with acute gastroenteritis in Qatar (AGE).
Results: E. coli were isolated and characterized from 76 diarrheagenic stool positive samples, collected from
hospitalized children less than 10 years old. Isolates were tested for antibiotic susceptibility against eighteen
clinically relevant antibiotics using E-test method. Conventional PCR was performed to detect genes encoding ESBL
and virulence factors. Chi-square test was performed to compare the individual antibiotic resistance between EPEC
and EAEC.
A significant percentage (73.7%) of isolates were resistant to at least one antibiotic. Overall, high resistance (70%)
was reported to the first-line antibiotics such as ampicillin, tetracycline (46.4%), and sulfamethoxazole-trimethoprim
(42.9%). Further, 39.5% of the isolates were multidrug resistant (MDR), with 22.4% being ESBL producers. On the
other hand, all isolates were susceptible to carbapenem, fosfomycin, amikacin and colistin. The incidences of
resistance to the 18 antibiotics between EPEC and EAEC were not significantly different by Pearson chi -square test
(P > 0.05). Genetic analysis revealed that 88.23% of ESBL production was bla CTX-M-G1 (bla CTX-M-15, bla CTX-M-3) -
encoded. Several different combinations of virulence markers were observed, however, there was no specific trend
among the isolates apart from absence of the bundle-forming pilus (bfpA) gene, which encodes the type IV
fimbriae in EPEC adherence factor (EAF) plasmid (pEAF), among all EPEC (atypical). 15% of the EAEC strains were
positive for a combination of astA, aap & capU, while 10% were positive for three different combinations. The aap,
aatA, capU and aggR virulence genes showed the highest frequency of 65, 60, 55 and 55% respectively. Others
genes, east, astA, and aai, showed frequencies of 35, 30 and 20% respectively.
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Conclusions: Atypical EPEC and EAEC were the primary etiological agents of diarrhea in children among DEC
pathotypes. Our results indicated high rate of antimicrobial resistance pattern of DEC strains, which necessities the
development of regulatory programs and reporting systems of antimicrobial resistance in DEC and other AGE-
associated bacteria to insure effective control of diarrheal diseases. Results from this study demand a further
research on identifying the phenotypic and genotypic profiles of more DEC pathotypes in various clinical samples.
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Background
Different pathotypes of diarrheagenic Escherichia coli
(DEC) are the main cause of pediatric diarrhea world-
wide, particularly in developing countries [1, 2] and trav-
elers to those countries. DEC strains have been classified
into five main types based on their specific virulence fac-
tors, clinical manifestations of the disease, epidemiology
and phylogenetic profile. These bacteria are Enteroag-
gregative E. coli (EAEC), Enteropathogenic E. coli
(EPEC), Enterotoxigenic E. coli (ETEC), Enteroinvasive
E. coli (EIEC), and Enterohemorrhagic E. coli (EHEC)
[3]. The progressive increase of antibiotic resistance
(AR) continues to pose a great threat to public health in
both developed and developing countries [4, 5]. The
treatment of Enterobacteriaceae family, including E. coli,
has been increasingly complicated by the emergence of
resistant strains to most first-line antimicrobial agents
[6, 7]. Many patients with gastroenteritis are empirically
treated with antibiotics, which could be ineffective in
many cases such as ampicillin, and ciprofloxacin in
adults. This misuse of antibiotics in treating diarrhea, es-
pecially in the developing world where the rate of diar-
rheal diseases is the highest and the use of antimicrobial
agents is often indiscriminate, could lead to increased
AR [8]. A distressing increase in multi-drug resistant en-
terobacteriaceae, particularly to third-generation cepha-
losporins and colistin (last resort antibiotic used to treat
carbapenem-resistant enterobacteriaceae), has been re-
ported in different regions [9–12].
Information about AR among DEC is important in
selecting the appropriate therapy. Little is known about
AR profile of DEC isolated from diseased children in the
Middle East and North Africa region (MENA) [13]. In a
study among pediatric patients who were admitted to
Jeddah hospital, the prevalence of enteropathogenic E.
coli was 3.8% and enterohaemorrhagic was 1.9% [14]. In
another study from the United Arab Emirate, the preva-
lence of ESBL among EAEC isolated from children pre-
sented with diarrhea was 11.3%. The objectives of this
study are to: (1) determine the prevalence of EAEC and
EPEC, the most prevalent, among children suffering
from acute gastroenteritis in Qatar; (2) determine
phenotypically and genotypically the AR profiles; and (3)
determine the prevalence of virulence genes in these
DEC.
Methods
Clinical isolates
A total of 175 fecal samples were collected between Au-
gust 2017 and January 2108 from children (0–10 years of
age) of different nationalities, hospitalized with AGE as-
sociated with diarrhea, vomiting and fever, at the
Pediatric Emergency Center (PEC)-Hamad Medical Cor-
poration (HMC). All samples were collected with in-
formed consent signed by the parents/legal guardians
under IRB approval # 16173/19 from HMC and Qatar
University approval number MRC-16173/16 and QU-
IRB605-E/16, respectively. For each individual, demo-
graphic data such as age, nationality, and gender were
collected. Samples were initially screened with Film
Array Gastrointestinal (GI) Panel kit (BIOFIRE®, Cam-
bridge, USA) for viral, bacterial and parasitic agents as-
sociated with AGE. Leftover stool samples (~ 0.5 g) were
individually diluted into 4 ml of PBS each to get the
stool suspension. Ten percent glycerol was added to
each tube before storing at − 80 o C for downstream ap-
plications. In total, 76 fecal samples were utilized in this
study, 56 of which were EPEC and 20 were EAEC as de-
tected with Film Array GI kit.
Bacterial culture
To isolate E. coli, 20 μl of stool suspension was inocu-
lated and streaked directly onto a selective medium
CHROMagar™ E. coli plates (Difco, Becton Dickenson,
Sparks, MD) using sterile cotton-tipped swabs, and then
incubated at 37 °C for 18–24 h. A typical single E. coli
colony (green color with smooth surface) was randomly
selected and subsequently streaked onto MacConkey
agar (Difco, BD) plates and incubated at 37 °C for 18–24
h. Lactose fermenter pink dry colonies were selected and
streaked onto fresh blood agar plates and incubated
again at 37 °C for 18–24 h. Colonies from the blood agar
were tested for conversion of tryptophan into indole
using Indole spot test (Remel, Thermoscientific, KS,
USA). E. coli colonies were further confirmed biochem-
ically by BIOMIC V3 (Giles Scientific, USA). The
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confirmed E. coli isolates were transferred to Cryovial
tubes (TechnicalService, Lancashire, U.K.) and stored at
− 80 °C until further analysis.
DNA extraction and polymerase chain reaction (PCR)
PCR was used to differentiate DEC into EPEC and EAEC
based on the presence of virulence genes. First, DNA
was extracted from bacterial cultures using QIAamp®
UCP pathogen mini Kit (Qiagen, Germany) following
manufacturer’s instructions and then used to run a com-
bination of uni- and multiplex PCR assays targeting 12
genes using previously published primers (Table 1). Uni-
plex PCR was performed to detect eae, tir, bfpA and
capU virulence genes. Conditions for reactions were as
follows: PCR mixture was made in volume of 20 μl con-
taining 0.5 μM of each pair of primers, 30 ng DNA, 10 μl
of Hot star Taq plus master mix (Qiagene, Germany), 1x
of Corolload load concentrate and DPEC H2O up to
20 μl. The reactions were amplified in Biometra TAd-
vanced thermocycler (analyticjena, Jena, Germany). Con-
ditions for amplification were carried out as described in
previous studies [15–19]. The Multiplex PCR (MPCR)
was performed to detect aap and aatA genes (MPCR1),
aai and astA genes (MPCR2), aggR and east (MPCR3)
and MPCR4 to detect sxt1 and sxt2. MPCR1 was per-
formed in a final volume of 30 μl, containing 0.5 μM of
each primer, 30 ng DNA, 15 μl master mix (Hot star Taq
plus master mix (Qiagen, Germany), 1x Corolload load
concentrate, and DPEC H2O up to 30 μl. MPCR2 was
performed in a final volume of 25 μl containing 0.4 μM
of each primer, 30 ng DNA, 12.5 μl master mix (Hot star
Taq plus master mix (Qiagene, Germany), 1x Corolload
load concentrate, and DPEC H2O up to 25 μl. MPCR3
and MPCR4 were performed in a final volume of 30 μl,
containing 0.5 μM of each primer, 30 ng DNA, 15 μl
master mix (Hot star Taq plus master mix (Qiagen,
Germany), 1x Corolload concentrate, and DPEC H2O
up to 30 μl. Amplified products were subjected to elec-
trophoresis in 1.2% agarose (Agarose- LE, Ambion®,
USA), stained with 0.2 mg/ml ethidium bromide (Pro-
mega, Madison, USA), and visualized using iBright
CL1000 imaging system (invitrogen, US).
Antimicrobial susceptibility testing
Antimicrobial susceptibility test was performed using
standard E test strips (E-test strip Diagnostic Liofilchem®,
Italy) technique in accordance with the recommendations
of CLSI, 2017 [21]. Zone of inhibition was examined to
determine the minimum inhibitory concentration [22]
values that were interpreted according to the CLSI guide-
lines [21]. ATCC E. coli strains number 25922 and 35,218
were used as susceptible and β-lactamase producing
Table 1 Primers used to amplify selected pathogenic E. coli virulence genes
Organism Primer sequence (5′→ 3′) Target gene Size (bp) Reference
Enteropathogenic
E.coli (EPEC)
GACCCGGCACAAGCATAAGC
CCACCTGCAGCAACAAGAGG
eae 384 [15]
EPEC CAGCCTTCGTTCAGATCCTA
GTAGCCAGCCCCCGATGA
tir 400 [16]
EPEC AATGGTGCTTGCGCTTCGTGC
GCCGCTTTATCCAACCTGGTA
bfpA 326 [15]
Enteroaggregative E.coli (EAEC) CTA ATT GTA CAA TCG ATG TA
AGA GTC CAT CTC TTT GAT AAG
aggR 457 [17]
EAEC CTT GGG TAT CAG CCT GAA TG
AAC CCA TTC GGT TAG AGC AC
aap 310 [17]
EAEC CTG GCG AAA GAC TGT ATC AT
CAATGT ATA GAA ATC CGC TGT T
aatA 629 [17]
EAEC ATGAATATACTATTTACGGAATC
CTACAGGCACAGAAAATGCCGATG
capU 776 [16]
EAEC CTC TTA GCA GGG AGT TTG TC
GCT TTG TTT ACC GAC TGA AC
aaiA 430 [18]
EAEC CCA TCA ACA CAG TAT ATC CGA
GGT CGC GAG TGA CGG CTT TGT
astA 111 [18]
EAEC CACAGTATATCCGAAGGC
CGAGTGACGGCTTTGTAG
east 97 [19]
* EPEC/EHEC ATAAATCGCCTATCGTTGACTAC
AGAACGCCCACTGAGATCATC
SXT1 180 [15]
* EPEC/EHEC GGCACTGTCTGAAACTGCTCC
TCGCCAGTTATCTGACATTCTG
SXT2 225 [15]
*The Enterohemorrhagic E. coli (EHEC) pathotype can be identified by the presence of the eae gene along with stx1 gene, stx2 gene, or both [20]. Therefore, to
differentiate between EHEC and EPEC we screen for the presence of stx1 gene, stx2 gene
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control strains9, respectively. The 18 antibiotics used to
screen the antibiotic susceptibility of EPEC and EAEC are
colistin, piperacillin/tazobactam, fosfomycin, ciprofloxa-
cin, nitrofurantoin, amikacin, ampicillin, cephalothin,
cefuroxime, ceftriaxone, cefepime, tigecycline, amoxicil-
lin /clavulanic acid, ertapenem, meropenem, trimetho-
prim/sulfamethoxazole, tetracycline, and chloramphenicol.
The 18 clinically relevant antibiotics used to screen
the antibiotic susceptibility of E. coli are summarized
in Supplementary 1.
Phenotype confirmation and molecular genotyping of
extended-spectrum β-lactamase (ESBL) genes
In recent years, there are major concern about antibiotic
resistant genes encoding ESBLs. The ESBL confer resist-
ance to penicillins and cephalosporins 1st, 2nd & 3rd
generations and are non-inhibited by inhibitors such as
clavulanic acid and tazobactam. ESBL producing strains
often exhibit multidrug resistance, including resistance
to aminoglycosides and fluoroquinolones, thus limiting
the therapeutic options. β- Lactam antibiotics are the
most widely used for all systemic infections. For these
reasons, this study has concerned to identify the occur-
rence of ESBL among DEC and detect the genes respon-
sible for ESBL production.
Isolates that were tested positive for third generation
cephalosporin were consequently confirmed by Double
Disc Synergy Test, (DDST) as previously described [21, 23].
Molecular genotyping of isolates exhibiting ESBL was per-
formed by characterization of the presence/absence of 10
genes namely, bla CTX-M-G (1, 2, 8, 9, &25), bla TEM and bla
SHV as described by [24]. Furthermore, in this study we tar-
geted the presence of blaCTX-M − 14 and stratified the CTX-
M-G1 to specify CTX-M-3 or CTX-M-15 type’s resistant
genes. We identify them with PCR product size of 335, 479,
and 996 bp respectively, by application of uniplex and
multiplex PCR. Briefly, PCR reactions were performed in a
total volume of 20 μl containing 0.5 pmol of each two pairs
of previously published primers namely, F-5’CACACGTG
GAATTTAGGGACT3’ and R-5′ GCCGTCTAAGGCGA
TAAACA3’ [25] for bla CTX-M-15; F-5’AATCACTGCGC
CAGTTCACGCT3’ and R- 5’GAACGTTTCGTCTCCC
AGCTGT3’ for blaCTX-M-3 [26]; F-5’TACCGCAGATAAT
ACGCAGGTG3’ and R-5′ CAGCGTAGGTTCAGTGCG
ATCC 3′ for blaCTX-M-G-14 [26]. 10 μl of HotStar Taq plus
master mix (Qiagen, Germany), 2 μl of 1 x Corolload con-
centrate, 2 μl of DNA samples and DPEC H2O up to 20 μl.
The reactions were amplified in Biometra TAdvanced ther-
mocycler (Analyticjena, Jena, Germany). NCTC E. coli
strains 13,461, 13,462, and 13,463; Enterobacter cloacae 13,
464, E. coli 13,353 and Klebsiella pneumoniae 13,465, E. coli
ATCC 35218 and E. coli NCTC 13368 were used as posi-
tive controls in PCR assays for CTX-MG1, CTX-MG2,
CTX-MG8, CTX-MG9, CTX-MG15, CTX-MG25 bla
TEM and bla SHV, respectively. Amplified products were
subjected to electrophoresis in 1.2% agarose (Agarose- LE,
Ambion®, USA), stained with 0.2mg/ml ethidium bromide
(Promega, Madison, USA), and visualized using iBright
CL1000 imaging system (invitrogen, US).
Sequencing and sequence analysis
Amplicons products that obtained from PCR reactions
targeting virulence genes were purified by ExoSAP-IT (GE
Healthcare life science, Chicago, USA) according to the
manufacturer instructions, and then subjected to sequen-
cing reactions using specific forward and reverse primers
for each gene (Table 1) with Big DyeTerminator Reaction
Mix (Applied Biosystems, USA). The reaction products
were purified using Big Dye XTerminator purification Kit
(Applied Biosystems) per manufacturer instructions and
run on ABI 3500 XL sequencer (Fisher scientific, USA).
The sequencing of the virulence gene amplicons were
confirmed using on line NCBI blast tool.
Data analysis
Data were introduced into Microsoft Excel 2010 (Micro-
soft Corporation, New York, USA) to generate figures
and run initial analysis and further statistical analysis
was performed using SPSS statistics 25 (Statistical Pack-
age for the Social Science; SPSS Inc., Chicago, IL, USA).
To compare the individual antibiotic resistance between
EPEC and EAEC, chi-square test was calculated using
Pearson probability value (P value). P-value less than
0.05 was considered statistically significant.
Results
Demography of the study population
A total of 175 collected stool samples were screened for
DEC. Only those intreperpreted as positive for EPEC
and EAEC were included in the study and characterized
in details.
The demographic profile of the studied population is
summarized in Table 2. About 55% of samples were col-
lected from males compared to 44.7% from females (0–
10 years of age), with female to male ratio of 1:1.2. DEC
were more prevalent among Qataris (43.4%) compared
to other nationalities: Pakistani (10.5%); Egyptians (9.2);
Syrian (9.2%); Indians (6.6%); Iranian and Sudanese
(3.9%); Algerian, Yemeni and Filipino (2.6%); and Ameri-
can and Moroccan (1.3%). Most of the DEC detected
during this study were among children less than 2 years
of age (59.2%), compared to those of the age between 2
and 5 years (23.6%) and 6–10 years (17%).
Pathotyping of DEC in stool samples from children with
AGE
According to the film array testing our 175 diarrhea-
genic stools samples from AGE children were classified
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as EPEC (56/175, 32%), the most predominant pathogen
followed by EAEC (20/175, 11.43%), then EIEC (8/175,
4.6%), ETEC (1/175, 0.6%) and the rest other causes.
Only EPEC and EAEC were further tested for their
AMR profile due to their significant numbers.
Phenotypic resistance profile
The percentage of the antibiotics resistance profile
against 56 EPEC and 20 EAEC is depicted in Fig. 1. In
general, EPEC and EAEC isolates were respectively
showing high resistance to ampicillin (51.7, 70%),
followed by tetracycline (46.4, 35%), trimethoprim/ sulfa-
methoxazole, (42.9, 30%), and cephalosporins: cephalo-
thin (26.8, 35%), cefuroxime (23.3, 20%) and ceftriaxone
(23.3, 20%). Relatively, less resistance was recorded
against amoxicillin/clavulanic acid (7.1, 15%), gentamicin
(5.5, 10%), cefepime (3.6, 10%) ciprofloxacin (7.1, 10%)
and chloramphenicol (8.9, 10%). EPEC isolates exhibited
3 and 3.6% antibiotic resistance against piperacillin/tazo-
bactam and nitrofurantoin, respectively whereas EAEC
isolates were entirely susceptible. All EPEC and EAEC
isolates were susceptible to meropenem, ertapenem, fos-
fomycin, colistin and amikacin. Thirteen isolates (23.2%)
of EPEC as well as 4 isolates of EAEC (20%) were ESBL
producers. Further 39.3% (22), and 40% (8) of EPEC and
EAEC respectively (Table 3), were multidrug resistant
(MDR): these are defined as acquired non-susceptibility
to at least one agent in three or more antimicrobial cat-
egories [27]. The incidences of resistance to the 18 anti-
biotics between EPEC and EAEC were not significantly
different by Pearson chi -square test (P > 0.05).
Genotypic resistance profile
Seventeen isolates were confirmed to be ESBL pro-
ducers, including 13 EPEC and four EAEC. The geno-
typic profiles were characterized with PCR for genes
encoding resistance (Fig. 2, Table 4).
A combination of bla CTX-MG1 (CTX-M-15, CTX-M-
3), and bla TEM genes (76.9%) encoded the highest resist-
ance among EPEC, followed by 7.7% of bla CTX-M-G-1
(blaCTX-M-15, blaCTX-M-3), bla TEM and blaSHV, and 7.7%
bla CTX-M-G-2, bla CTX-M-G-8, bla CTX-M-G-9 and bla
CTX-M-G-14. On the other hand, the highest resistance
among EAEC (75%) was encoded by to blaCTX-M-G-1
(blaCTX-M-15, blaCTX-M-3), followed by 25% of blaTEM,
blaCTX-M-G-8, blaCTX-M-G14.
Virulence genes profile
The initial diagnosis for EPEC and EAEC pathotypes
was done at HMC using the “BioFire GI Panel test” (Bio-
merieux; Utah USA), which detect 22 of the most com-
monly pathogens associated with gastroenteritis. To
Table 2 Demographic profile of the study population (76) with DEC in the State of Qatar
Age group
(years)
Total number/percentage Nationality (Total number/percentage)
Male Female Qatari Non Qatari (n* = 12)
< 2 26 (34.2%) 19 (25%) 17 (22.4%) 28 (36.8%)
2–5 11 (14.5%) 7 (9.2%) 10 (13.2%) 8 (10.55)
6–10 5 (6.6%) 8 (10.5%) 6 (7.9%) 7 (9.2%)
*Represent the number of nationalities tested
Fig. 1 Comparison of phenotypic antimicrobial resistance profile of EPEC (56) and EAEC (20) isolated from children (age 0 to 10 years) suffering
from AGE. The figure depicts the percentage of isolates with resistance to 14 of the 18 tested antibiotics. AMC: Amoxicillin/Clavulanic acid; TZP:
Piperacillin/ Tazobactam; SXT: Trimethoprim/Sulfamethoxazole; P > 0.05 for the comparison between EPEC and EAEC against all antibiotics
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better understand the diversity of the circulating strains,
we further evaluated these two pathotypes by screening
for the most common virulence genes as described in
the literature (Table 1). EPEC strains were identified by
PCR assay using primers that target the eae (positive; en-
codes intimin) and stx (negative) genes. We also tested
EPEC strains for the presence of the bfpA (encoding
bundlin), noting that intimin and bundlin play important
roles in EPEC invasion of host cell through attachment
and eternalization. On the other hand, there is no con-
sensus on which EAEC genes are unambiguously patho-
genic, and hence, we selected several genes to screen for
in this study.
Among the 56 isolated EPEC strains, 50 (89.3%) were
positive for eae, and only 6 (10.7%) were positive for eae
and tir. All of isolated EPEC were atypical (absence of
Table 3 Phenotypic resistant pattern of EPEC (n = 56) and EAEC (n = 20) isolates from children with AGE
Resistant phenotype Frequency Percentage
EPEC EAEC EPEC EAEC
No resistance 16 4 28.6 20
*ampicillin, tetracycline, sxt 6 1 10.7 5
#ampicillin, cephalothin, cefuroxime, ceftriaxone 5 0 8.9 0
tetracycline 4 0 7.1 0
*chloramphenicol,tetracycline, sxt 2 0 3.6 0
*#ampicillin, sxt, cephalothin, cefuroxime, ceftriaxone 2 0 3.6 0
sxt 2 1 3.6 5
piperacillin 1 0 1.8 0
nitrofurantoin 1 0 1.8 0
ampicillin, amc, cephalothin 1 0 1.8 0
*ampicillin, amc, tetracycline, sxt 1 0 1.8 0
*ampicillin, gentamicin, ciprofloxacin, chloramphenicol, tetracycline, sxt 1 0 1.8 0
*ampicillin, chloramphenicol, tetracycline, cephalothin 1 0 1.8 0
*ampicillin, ciprofloxacin,tetracycline, sxt 1 0 1.8 0
tetracycline, sxt 1 0 1.8 0
*#ampicillin, tetracycline, sxt, cephalothin, cefuroxime,, ceftriaxone, cefepime 1 0 1.8 0
*ampicillin, chloramphenicol, tetracycline, sxt 1 0 1.8 0
*#ampicillin, chloramphenicol, tetracycline, sxt, cephalothin, cefuroxime, ceftriaxone 1 1 1.8 5
ampicillin, tetracycline 1 0 1.8 0
*#ampicillin, gentamicin, tetracycline, sxt, cephalothin, cefuroxime, ceftriaxone 1 0 1.8 0
*#ampicillin, tetracycline, sxt, cephalothin, cefuroxime, ceftriaxone 1 0 1.8 0
*#ampicillin, amc, tzp, ciprofloxacin, tetracycline, cephalothin, cefuroxime, ceftriaxone, cefepime 1 0 1.8 0
*#ampicillin, ciprofloxacin, tetracycline, sxt, cephalothin, cefuroxime, ceftriaxone 1 0 1.8 0
*ampicillin, amc, sxt 1 0 1.8 0
sxt, nitrofurantoin 1 0 1.8 0
ampicillin, tetracycline 1 1 1.8 5
ampicillin 0 4 0 20
*#ampicillin, amc, tetracycline, cephalothin, cefuroxime, ceftriaxone, cefpime 0 2 0 10
ampicillin, cephalothin 0 1 0 5
ampicillin, sxt 0 1 0 5
*ampicillin, chloramphenicol, tetracycline 0 1 0 5
*#ampicillin, ciprofloxacin, sxt, cephalothin, cefuroxime, ceftriaxone 0 1 0 5
*ampicillin, gentamicin, amc, cephalothin 0 1 0 5
*ampicillin, gentamicin, ciprofloxacin, cephalothin 0 1 0 5
amc amoxicillin/clavulanic acid, sxt trimethoprim/sulfamethoxazole, MDR multidrug resistant, esbl extended spectrum β- lactamase producer
*: MDR (n = 22 for EPEC and n = 8 for EAEC)
#: ESBL (n = 13 for EPEC and n = 4 for EAEC)
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Fig. 2 Detection of antibiotic resistance genes among 17 ESBL Enterobacteriaceae pathogens isolated from children with AGE. a: blaSHV, blaTEM
and blaCTX-M-G (1, 2, 8 &9). b: blaCTX-M-G (3, 14 &15). Representative samples are shown. Multiplex PCR was performed for detection of CTX-M
groups with exception of blaCTXM-G15, while monoplex PCR was used for detection of TEM and SHV. The amplification products of each isolate
were run on the same lane for detection of bla genes. a Lane 1: blaCTXM-G1, blaTEM, blaSHV; Lane 2: blaCTXM-G1, blaTEM; Lane 3: blaCTXM-G1,
blaTEM; lane 4: blaCTXM-G1; Lane 5: blaCTXM-G1, blaTEM; Lane 6: blaCTXM-G2, blaCTXMG8, blaCTXMG9; Lane 7: blaCTXM-G1, blaTEM; Lane 8: NCTC
13351 E. coli positive control for blaTEM, NCTC 13461 E. coli, positive control for blaCTX-MG1& NCTC 13368 K. pneumonia positive control for blaSHV;
Lane9: ATCC 25922 E. coli negative control; Lane 10: H2O negative control; M, molecular size (weight) standard marker; bp, base pairs. b: lanes (1–
5 &7–13): blaCTXM-G3 & blaCTXM-G15. Lane 6: blaCTXM-G14
Table 4 Distribution of bla genes obtained from diarrheagenic stool samples of children with acute gastroenteritis
Isolate Gene %
EPEC (n = 13 ESBL) CTX-M--G1(CTX-M-15, CTX-M-3) TEM,CTX-M-G-1(CTX-M-
15, CTX-M-3)
TEM, CTX-M-G-8,
CTX-M-G-14,
TEM, SHV, CTX-M-G-1
(CTX-M-15, CTX-M-3)
CTX-M-G-2, CTX-M-G-8,
CTX-M-G-9, CTX-M-G-14,
1 (7.7) 10 (76.9%) 0 1 (7.7%) 1 (7.7%)
EAEC (n = 4 ESBL) 3 (75%) 0 1(25%) 0 0
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bfpA). Of the 20 EAEC strains, three (15%) were positive
for a combination of astA, aap & capU, two (10%) were
positive for each of the following three combinations: 1.
aat, aai, astA, aggR, east, aap, capU; 2. aatA, aggR, east,
aap, capU; and 3. aatA, aagR, east & aap. No identical
virulence aap, aatA, capU and aggR showed the highest
frequency of 65, 60, 55 and 55% respectively. On the
other hand, east, astA, and aai showed frequencies of
35, 30 and 20% respectively (Fig. 3, Table 5). The se-
quence analysis of the detected virulence genes found to
have 99.7% similarity to (eae, Acc. No. MK761167);
97.4% to (tir, Acc.NoAF132728); 97% to (east, Acc. No.
LC312643) 98.7% to (capU, Acc. No. AF134403; 95.6%);
98.6% to (ast ACC. No. LC312643) and 97.3% to (aat A,
Acc. No. AY351861) sequence data were not shown.
Discussion
This is one of the few studies from the MENA region that
describe the AMR profile of DEC in the pediatric popula-
tion and to the best of our knowledge; this is the first
study that primarily investigated, the antimicrobial resist-
ance and virulence pattern of DEC among children in
Qatar. Most of the studies from the MENA region includ-
ing those from Qatar [28, 29], Jeddah [13, 14], Oman [30],
Kuwait [31], and Bahrain [32] focused mainly on the
prevalence but not the AMR of DEC in adults and chil-
dren. Very few studies from Iran [22, 33, 34], Libya [35]
and Egypt [36] explored the AMR profiling among DEC.
This highlights the critical need and the importance of this
study, considering the multinational composition of
Qatari population, where more than 80% of the popula-
tion are expatriates. From this study among children suf-
fering from AGE in Qatar, it was revealed that most of the
affected group are those less than 2 years of age (59.2%),
compared to older children, supporting other several stud-
ies worldwide [37–40]. Our results also depicted that
EPEC was the most predominant pathogen (32%) followed
by EAEC (11.43%). Accordingly, determining the virulence
and AMR profile of these pathogens is very crucial in pro-
viding adequate treatment to control infections, rather
than the empirical use of antibiotics that could lead to the
development of resistant strains. Here, we reported a sig-
nificant percentage of EPEC and EAEC isolates that are
resistant to at least one antibiotic (73.7%). Overall, our re-
sults showed high resistance to first-line antibiotics such
as ampicillin, tetracycline, sulfamethoxazole-trimethoprim
which is consistent with old and recent reports around the
Fig. 3 Detection of virulent genes among EAEC isolates. Representative samples are shown. Lane 1:astA; lane 2: astA; Lane 3: aatA; Lane 4: astA,
aatA; Lane 5: astA; Lane 6: aatA& aaiA; Lane7: aggR & east; Lane8: aggR & east; Lane 9: aggR & east; lane 10: aggR & east; lane11: aggR & east; lane
12: aggR & east; Lane 13: aggR; lane 14: negative control H2O; Lane 15:aap; Lane 16: aap & aatA; Lane 17: aap; M, molecular size (weight) standard
marker; bp, base pairs
Table 5 The prevalence of different virulence genes among
EPEC and EAEC strains isolated from children with acute
gastroenteritis
EAEC virulence genes profile Frequency Percentage%
aatA, astA,aggR, aap & capU 1 5
aatA,astA, east, aap & capU 1 5
aatA, aaiA, astA, aggR & capU 1 5
aatA, aggR, east, aap & capU 2 10
aatA, astA, aggR, east, aap & capU 1 5
aatA, aaiA, aggR, east, aap & capU 1 5
aatA, aaiA, aggR, aap & capU 1 5
aatA, aaiA, astA, aggR, east, aap & capU 2 10
aatA, aggR, aap & capU 1 5
aatA, aggR, east & aap 2 10
aatA, aggR & east 1 5
astA, aap & capU 3 15
aatA, aggR &aap 1 5
aap & capU 1 5
aap 1 5
EPEC virulence genes
eae 50 89.3
eae & tir 6 10.7
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globe [9, 22, 33, 36];. These first line antibiotics are widely
empirically used in developing countries to treat diarrhea
because of their low cost and availability [8, 41]. Alarm-
ingly, about 40% of the isolates were MDR, with more
than 20% being ESBL producers. In contrast to our find-
ings, a relatively recent study from Tennessee, USA (Fos-
ter et al., 2015) showed that DEC isolates from children
less than 12 years old with AGE were susceptible to the all
antibiotics tested, with the exception of Ampicillin (5/12,
41.6%). On the other hand, several regional and inter-
national studies have reported similar findings to ours
about multi-drug resistant and ESBL producers among
DEC [9, 22, 42]. The worldwide prevalence of high resist-
ance in DEC could be attributed to the inappropriate and
wide use of different antibiotics to treat infection in
children of a young age. Unless the patient is immuno-
compromised, the current practice in Qatar to treat chil-
dren with AGE is primarily supportive, without the use of
antibiotics. This has been the practice since the imple-
mentation of antibiotics stewardship program in Qatar’s
main hospitals during 2017. Still, the acquisition of resist-
ance could be attributed to many factors including fre-
quent travel, the uncontrolled use of antibiotics by
patients’ families that bring it without prescription from
their home countries, knowing that more than 80% of
Qatar population are expatriates arriving from many
countries in MENA region and Southeast Asia. At the
local level, our group has recently reported 27% MDR and
9% ESBL among commensal E. coli isolated from healthy
food handlers in Qatar [43]. Accordingly, the food chain
could be another factor for the dissemination of resistant
E. coli. Particularly, the pathogenic potential of EAEC has
been associated with the emergence of food-borne out-
breaks, most notably in Germany in 2011 [44].
Our current findings showed that all EPEC and EAEC
isolates were susceptible to meropenem, ertapenem, fos-
fomycin, amikacin and colistin. This might be attributed
to the low prescription and consumption of these antibi-
otics in Qatar’s health care facilities, reflecting the com-
pliance with the antibiotic guidelines and stewardship
program. Cumulatively, our findings indicate that ampi-
cillin and trimethoprim-sulfamethoxazole are redundant
as first line empirical antibiotics for the treatment of
diarrhea in acute cases and alternatives should be con-
sidered. The high prevalence (22. 4%) of ESBLs in our
study carries tremendous clinical significance in terms of
infection management and control. The ESBLs are pri-
marily plasmid encoded and frequently carry genes en-
coding resistance to other drug classes for example,
aminoglycosides [45]. Therefore, antibiotic options in
the treatment of ESBL-producing organisms are ex-
tremely limited. Carbapenems are the treatment of
choice for serious infections with ESBL-producing or-
ganisms, to which, DEC remains largely susceptible in
this study. In the future, selective pressure on carbapen-
ems could accelerate the development of carbapenemase
resistant that already detected in several parts of the
world [46–49].
Molecular analysis of resistant isolates to third gener-
ation cehalosporins indicated the presence of at least
two genes that encode resistance. We observed a posi-
tive correlation between phenotypic and genotypic pro-
files (CTX-M, SHV and TEM) in all the isolates. In both
bacterial species, EPEC and EAEC, blaCTX-M was most
prevalent ESBL encoding gene, which is very similar to
what we have recently reported in enterobacteriaceae
isolates from children suffering from urinary tract infec-
tion (23) indicating that there might be a transfer of bac-
teria from gut to the urinary system. We have not
observed any specific pattern or trend of higher MICs
and the gene detected. Presence of any of these genes
does not predict the association of resistance to quin-
olone and aminoglycoside. Without any exception, all
isolates harbored blaCTX-M gene (100%), primarily
blaCTX-MG1, which includes blaCTX-M-3 &15 (88.23%).
This is in accordance with our previous study on E. coli
ESBL producers isolated from children with urinary tract
infection, where CTX-MG1 was present in more than
89% isolates [24]. That study did not investigate the type
of E. coli causing the diseases and hence, we could not
associate the present findings with our previous urinary
tract study. However, it has been shown in several occa-
sions that EAEC can be associated with urinary tract in-
fection [50, 51].
On the other hand, this study revealed a high degree
of variability of virulence markers among EAEC isolates
(Fig. 3, Table 5), with 15 patterns were documented, in-
dicating the diversity of their origin and heterogeneity
with respect to virulent genes. An earlier study from Iran
[33] reported similar findings about high frequency of
aggR, aap and astA virulence genes from children with
diarrhea. In our study, 14 isolates (70%) harbored aggR,
indicating typical EAEC. Nine of EAEC (45%) in this
study harbored astA gene, which was considered in the
past a characteristic of EAEC strains [52]. However, this
gene has been detected in only a subgroup of EAEC and
has an extensive distribution among other pathogenic
and non-pathogenic E. coli strains [53]. All 56 EPEC iso-
lates were atypical, harboring only eaeA (absence of bfpA
gene), whereas in typical EPEC both genes eaeA and
bfpA are present [22, 54]. Similar to our findings, in the
MENA region, atypical EPEC strains have been the most
manifested in Iran (100%), Iraq (66.7%) and Kuwait
(95.6%) [34, 55, 56]. They have been also reported in
other countries worldwide, such as Brazil, North-West
Italy, Melbourne, India [56–60]. In agreement with our
findings, the atypical EPEC organisms that possess eae
alone have been reported to be more prevalent in both
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developing and developed countries. Animals can be res-
ervoirs of atypical EPEC, in contrast to typical EPEC, in
which humans are the sole reservoir [61], indicating that
food chain and animal contact could be other factors for
the dissemination of resistant DEC among pediatrics in
Qatar. In contrast with our findings, studies from Iraq
and India documented atypical EPEC harboring bfpA
without eaeA gene [34, 56]. Early studies conducted in
England and Peru have shown that atypical EPEC is
often found in children with and without diarrhea, and
the pathogenic potential of atypical EPEC strains has
been speculative in the past [62, 63]. A recent publica-
tion by the Global Enteric Multicenter Study (GEMS)
confirmed atypical EPEC as the fifth most frequently de-
tected pathogen in patients aged 0–11months with AGE
[20]. Further surveillance studies in Qatar that include
healthy controls may provide indications on host risk
factors as well as EPEC virulence factors that are associ-
ated with the disease.
This is the first study to characterize the AMR profile
of DEC strains, particularly EAEC and EPEC, in Qatar.
This study was restricted to only two types of DEC in
children suffering from AGE, while a comprehensive
study that investigate the prevalence and characteristics
of more DEC types in different age groups, in healthy
and diseased population, might be needed.
In conclusion, our data indicate the importance for
routine laboratory detection of DEC strains coupled with
performing sensitivity testing, since diagnostic tools to
differentiate these E. coli pathotypes are not routinely
readily available in all clinical laboratories in Qatar.
Findings from our study could be used to develop rec-
ommendations for treating infections with DEC bacteria,
especially in the pediatric populations. Knowledge of
antimicrobial resistance of DEC is important in selecting
the appropriate therapy in serious diarrheagenic infec-
tions and formulating local antimicrobial guidelines.
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